Related Experiment Video

Updated: Apr 21, 2026

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
07:10

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on: January 7, 2019

14.1K

The clinical management of HCV in the HIV-infected patient

Brianna Norton1, Susanna Naggie

  • 1Department of Medicine, Montefiore Medical Center, Bronx, NY, USA. bnorton@montefiore.org.

Antiviral Therapy
|October 28, 2014
PubMed

Insights

Hepatitis C (HCV) treatment is crucial for HIV-HCV coinfected individuals, as achieving a sustained viral response (SVR) significantly reduces liver disease mortality. Newer, interferon-free regimens offer simpler, safer treatment options.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Virology

Background:

  • Chronic hepatitis C (HCV) affects 170 million globally, with frequent coinfection in HIV patients.
  • HIV coinfection accelerates liver disease progression and increases liver-related mortality.
  • Improved HIV management leads to increased non-AIDS complications, including liver disease from HCV.

Purpose of the Study:

  • To emphasize the critical importance of HCV treatment in HIV-HCV coinfected patients.
  • To highlight the benefits of achieving sustained viral response (SVR) in reducing mortality.
  • To introduce the advantages of novel, interferon-free HCV therapies.

Main Methods:

  • Review of current understanding of HIV-HCV coinfection and liver disease progression.
  • Analysis of the impact of sustained viral response (SVR) on patient outcomes.
  • Discussion of emerging interferon-free treatment regimens for HCV.

Main Results:

  • HIV coinfection is an independent predictor of liver disease progression.
  • Sustained viral response (SVR) is associated with significantly reduced liver disease mortality.
  • Newer all-oral, interferon-free regimens simplify treatment and reduce side effects and drug interactions.

Conclusions:

  • HCV eradication through SVR is imperative for improving survival in coinfected patients.
  • Interferon-free regimens represent a significant advancement in simplifying and improving HCV treatment for HIV-coinfected individuals.
  • Prompt and effective HCV therapy is essential for managing coinfected populations.

More Related Videos

A Protocol for Analyzing Hepatitis C Virus Replication13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

23.7K
Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models09:54

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models

Published on: December 3, 2019

9.2K

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
73
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
42.7K
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion...
16
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
864
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
340
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
533